Personalized fibrinogen dosing after heart surgery
Treatments studied
Part of Blood & lymphatic, Heart & circulation clinical trials.
This trial tests whether giving a personalized dose of fibrinogen, a protein that helps blood clot, after heart surgery reduces bleeding and the need for blood transfusions. It aims to improve recovery for patients who need fibrinogen after being on a heart-lung machine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older).
- You are having heart surgery that uses a heart-lung machine (cardiopulmonary bypass).
- Your doctor decides you need fibrinogen after the surgery to help your blood clot.
- You are covered by social security (health insurance) and can speak French.
- You are not pregnant, breastfeeding, or in labor.
- You do not have certain bleeding disorders or a very low red blood cell count.
- You are not in a life-threatening situation with less than 24 hours to live.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks back at patient records from heart surgeries that used a heart-lung machine to see how the availability of a medicine called fibrinogen affected blood transfusions and recovery. It helps us understand if wider access to this treatment improves outcomes.
This trial checks if a fast bedside test for fibrinogen (a protein that helps blood clot) can help guide treatment for trauma patients who are actively bleeding. It may lead to better care in the emergency department.
This trial tests whether giving fibrinogen, a protein that helps blood clot, reduces bleeding during liver transplant surgery. It may help patients with certain liver conditions who are at higher risk of bleeding.
This trial is for hospitals, not patients. Hospitals that do many open heart surgeries and whose doctors agree to use certain bleeding control drugs (fibrinolysis inhibitors) as per the study protocol can participate.
This trial compares two treatments for bleeding after heart surgery: a medicine called FEIBA (which helps blood clot) and fresh frozen plasma (a blood product). The goal is to see which works better as a first treatment for bleeding during recovery.
This trial tests a medicine called 4F-PCC to stop bleeding during complex heart surgery that uses a heart-lung machine. It could help people who have bleeding problems after the surgery.
Hear when a new Fibrinogen Deficiency in Complex Cardiac Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.